Educate. Enlighten. Empower.

Women in pharma, unite! Respected and accomplished female professionals at the forefront of pharma are ready to show you that together, we’re better. This unique forum gives you the opportunity to:

  • Connect and collaborate with high-achieving female pharma professionals through relaxed and comfortable networking.
  • Discover new ways to unleash your potential—together with your contemporaries—with candid discussions, knowledge-sharing, and inspirational stories.
  • Gain a whole new industry perspective by hearing strategies for leadership and advice on overcoming workplace challenges—by women of pharma, for women of pharma.


2017 Attendees said...

"Great panel & speakers. Taking time to talk about self & career is important & not always possible. I like hearing other women's stories."

"Very thought provoking."

"Really appreciate the more diverse discussion about women in the global business market."

2018 Program

Thursday 26th April, 8:00-11:30am, Pennsylvania Convention Center (1101 Arch Street Philadelphia, Pennsylvania 19107). Located in room 108A.

Please note schedule subject to change. 

08:00 – 08:30 | Breakfast & Networking
Start your day at CPhI North America by networking with like-minded women in Pharma

08:30 – 08:35 | Welcome from the Chair
Rachel Klos, Senior Manager, Content Marketing Operations, Clarivate Analytics

08:35 – 09:05 | Keynote
Lynn Taylor, Senior Vice President, Head of Healthcare Global Government and Public Affairs, Head of Corporate and Government Relations USA, Merck KGaA, Darmstadt, Germany

09:05 – 10:10 | Panel Discussion and Q&A: Empowering Women to Thrive
How can you leverage your support systems to realize your potential? Topics to include:

  • Mentoring - helping each other to succeed
  • Corporate strategies & company culture
  • Self-empowerment - what can you do to create your own opportunities?
  • Paying it forward

Moderator: Alize Cortez, Consultant at Insigniam / Radio Podcast Host
x Hugh Welsh, General Counsel, Secretary & President DSM North America 
x Mike Kosko, Vice President, Active Pharmaceutical Ingredients and Corporate Sponsored Agreements, Pfizer CentreOne
x Tina Garyantes, Vice President, Therapeutics, Chromocell

10:10 – 11:00 | World Café (dynamic networking space)
Join group discussions focusing on answering your questions and discussing yours, the panel's and your peers' experiences.

11:00 – 11:30 | Coffee & Networking


Questions about the line up? Contact us at [email protected]

Meet our Chair

Rachel Klos is the Senior Manager, Content Marketing Operations for Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation. In this role, she is responsible for driving and facilitating thought leadership quality and consistency through best practices in development, publication, and promotion.

Prior to leading content marketing operations for Clarivate, Rachel was the global marketing lead for the company’s generics and API segment, where she led business development campaigns, industry reports, and retention communications for generics, innovator, and drug manufacturing customers of the Newport product suite. She holds nearly ten years of experience in B2B marketing, proposal writing, graphic design, and communications for international organizations.

In addition to her roles in marketing and communications, Rachel is also a Geis women’s studies research awardee, community organizer for women’s advocacy initiatives, and trauma-sensitive yoga instructor for women in transitional housing. She holds degrees in English and Women’s Studies, and serves on the leadership board of [email protected] – Philadelphia, a corporate initiative focused on attracting, retaining, developing, and advancing women in the workplace. Rachel is a regular speaker and community educator for Women Against Abuse, Philadelphia’s leading organization in the fight to end domestic violence, and a longtime member of the United Way “Women United” leadership Initiative.

Meet Our Moderator

Alise Cortez, PhD, is a Consultant at Insigniam, an international management consulting firm. She also serves as Adjunct Faculty at Southern Methodist University. Alise has been researching the manner in which people find meaning in their work for the last 15 years. This laborious and rewarding research has culminated in a book she is currently writing, along with a weekly radio show called "Working on Purpose" she hosts on the Voice America’s Empowerment channel. She is conversationally comfortable in Spanish and Portuguese, with some exposure to Italian and French.

Across a breadth of industries and geographies, Alise is regarded as an expert in organizational development, complex enterprise strategy implementation, and leadership transformation and development. With her 20+ years of experience in the human resources and consulting fields, clients seek Alise’s experience in transformational consulting and executive coaching to develop potent leaders and accomplish strategic business objectives.

Alise holds a PhD in Human Development from Fielding Graduate University in Santa Barbara, California, a Master of Arts in Liberal Studies from the University of Oklahoma, and a Bachelor of Arts in Liberal Studies from the University of Iowa. Through extensive travel and living abroad in Western Europe and South America, she has also developed deep knowledge and appreciation of several cultures and understands how diversity improves bottom-line business results.

Alise is passionate about travel across the globe, learning new languages, connecting with and experiencing diverse cultures, fitness and health, and her daughter.

Meet Our Speakers

In her role as Head of Healthcare Global Government & Public Affairs, Lynn positions the Healthcare sector of Merck KGaA, Darmstadt, Germany, as the partner of choice to ensure new medicines are brought to patients around the world.  Lynn and her team work on a global basis to shape government public policies, enhance the company’s reputation and build relations with key external stakeholders, including with patient groups and professional societies. In her capacity as Head of Corporate and Government Relations, USA, Lynn is responsible for leading the company’s engagement with external stakeholders based in the USA on behalf of the company’s three business sectors: Healthcare; Life Science; and, Performance Materials. The objective being to positively impact public policy on cross-cutting policy topics and corporate reputation. 

Lynn joined the company in 2005 as Executive Director of US Government Relations, became Vice President of US Government Affairs and Head of the Washington, DC Office in 2006, and assumed the role of Senior Vice President and Head of Global Government Affairs and Policy for the Healthcare sector in 2013.  

Lynn joined the biopharmaceutical industry in 1997. She began her industry career in the field of health outcomes research working at MEDTAP International (currently UBC – An Express Scripts Company), where she conducted cost-effectiveness, cost-of-illness, and quality-of-life research on a broad range of disease areas for both pharmaceuticals and medical devices. She then took a variety of roles of increasing scope and responsibility in the areas of strategy, health policy, and government relations at the Pharmaceutical Research and Manufacturers of America (PhRMA), DEKA Research and Development, and Millennium Pharmaceuticals (currently Millennium: The Takeda Oncology Company).  

Lynn serves as Chairman of the German American Business Council (GABC) of Washington, DC, an independent, non-profit organization that fosters transatlantic business dialogue between Germany and the USA.  Lynn is also a member of the Board of Governors of the Bryce Harlow Foundation and the Board of Directors of Healthy Women.  The Bryce Harlow Foundation is a Washington, DC based not-for-profit organization dedicated to promoting the highest standards within the profession of lobbying and government relations.  Healthy Women is the leading not-for-profit in the USA dedicated to improving women’s health, both educating and empowering women to make informed health choices for themselves and their families and ensuring that women's health is a primary focus by policy makers and advocacy groups.

Lynn earned her master’s degree in public administration from American University in Washington, DC and her bachelor’s degree in political science from Fordham University in New York. She is married with two children and is based in Washington, DC.

Tina, a successful entrepreneur, leads Therapeutics at Chromocell having advanced Chromocell’s lead pain molecule into the clinic and partnered it with Astellas.   

Prior to joining Chromocell, she was co-founder and CEO of MaxSAR and global head of assay development and screening at Sanofi.

Tina invented the virtual well plate and outlicensed it to Becton Dickinson while at Merck and developed the first clinical instrument for fine structure analysis of DNA for the Mayo Clinic at Chiron Diagnostics.  She has a BSE in Bioengineering from UPenn and a PhD in Biophysics from Caltech where she led systems development at Cryopharm while completing her thesis.

She serves on numerous boards in addition to her work at Chromocell.

Michael J Kosko (Mike) is the Vice President for Active Pharmaceutical Ingredients (API) and Corporate Sponsored Agreements (CSA’s) in the Pfizer CentreOne organization. This area of Pfizer CentreOne is based in Kalamazoo (Michigan) with Business Development/Sales locations in Kalamazoo, Brussels (Belgium) and Singapore.  The API area includes both our Large Molecule and Small Molecule Drug Substance capabilities on a global basis. The group also manages CSA’s which are the result of a Pfizer Corporate divestment.

Mike holds a B.S. in Chemistry from the University of Connecticut and an M.B.A. from the University of New Haven. Mike and his wife reside in Mattawan, Michigan. They are parents to four grown children.

Mr. Welsh is the President, General Counsel & Secretary of DSM North America, a global leader in Life Sciences & Material Sciences. Traded on the Amsterdam stock exchange with 24,000 employees worldwide and $12 billion in annual sales, DSM develops, manufactures and sells nutritional and food ingredients, biomedical materials, specialty plastics and resins, fibers and renewable energy. Hugh currently serves on several DSM global and regional management teams and has direct responsibilities in DSM’s nutrition and food specialties operations as well as responsibility for legal, government affairs, communications, corporate partnerships and DSM’s sustainability initiatives in the North America region. Before joining DSM, Hugh worked for the American Standard Companies, McCarter & English LLP and others. Hugh currently serves on the Board of Directors of, Partners in Food Solutions, the Seafood Nutrition Partnership, Patheon, Africa Improved Foods and the US Chamber of Commerce Foundation. He received his Bachelor's Degree in Economics and History from the University of Massachusetts in 1990 and his Juris Doctorate in law from Seton Hall University School of Law in 1993.